Angiomotin Promotes Renal Epithelial and Carcinoma Cell Proliferation by Retaining the Nuclear YAP

Overview

Journal Oncotarget

Specialty Oncology

Date 2016 Feb 6

PMID 26848622

Citations 25

Authors

Meng Lv

Shuting Li

Changqin Luo

Xiaoman Zhang

Yanwei Shen

Yan Xia Sui

Fan Wang

Xin Wang

Jiao Yang

Peijun Liu

Jin Yang

Affiliations

Soon will be listed here.

Abstract

Renal cell carcinoma (RCC) is one of the common tumors in the urinary system without effective therapies. Angiomotin (Amot) can interact with Yes-associated protein (YAP) to either stimulate or inhibit YAP activity, playing a potential role in cell proliferation. However, the role of Amot in regulating the proliferation of renal epithelial and RCC cells is unknown. Here, we show that Amot is expressed predominantly in the nucleus of RCC cells and tissues, and in the cytoplasm and nucleus of renal epithelial cells and paracancerous tissues. Furthermore, Amot silencing inhibited proliferation of HK-2 and 786-O cells while Amot upregulation promoted proliferation of ACHN cells. Interestingly, the location of Amot and YAP in RCC clinical samples and cells was similar. Amot interacted with YAP in HK-2 and 786-O cells, particularly in the nucleus. Moreover, Amot silencing mitigated the levels of nuclear YAP in HK-2 and 786-O cells and reduced YAP-related CTGF and Cyr61 expression in 786-O cells. Amot upregulation slightly increased the nuclear YAP and YAP-related gene expression in ACHN cells. Finally, enhanced YAP expression restored proliferation of Amot-silencing 786-O cells. Together, these data indicate that Amot is crucial for the maintenance of nuclear YAP to promote renal epithelial and RCC proliferation.

Citing Articles

Determining the minimal amount of DMSO necessary to stabilize the Angiomotin lipid binding domain.

Araya F Indiana Univ J Undergrad Res. 2025; 8.

PMID: 39866826 PMC: 11759511. DOI: 10.14434/iujur.v8i1.31200.

PSAT1 promotes the progression of colorectal cancer by regulating Hippo-YAP/TAZ-ID1 axis via AMOT.

Tang M, Song K, Xie D, Yuan X, Wang Y, Li Z Mol Cell Biochem. 2024; .

PMID: 39739271 DOI: 10.1007/s11010-024-05194-8.

Emerging Role of Hippo-YAP (Yes-Associated Protein)/TAZ (Transcriptional Coactivator with PDZ-Binding Motif) Pathway Dysregulation in Renal Cell Carcinoma Progression.

Mondal V, Higgins P, Samarakoon R Cancers (Basel). 2024; 16(15).

PMID: 39123485 PMC: 11312123. DOI: 10.3390/cancers16152758.

Association of low angiomotin-p130 and high YAP1 nuclear expression with adverse prognosis in epithelial ovarian cancer.

Cai J, Han X, Li M, Liu X, Zhang F, Wu X Histol Histopathol. 2024; 40(1):57-65.

PMID: 38785315 DOI: 10.14670/HH-18-758.

Role of angiomotin family members in human diseases (Review).

Wang H, Ye M, Jin X Exp Ther Med. 2024; 27(6):258.

PMID: 38766307 PMC: 11099588. DOI: 10.3892/etm.2024.12546.

References

Aase K, Ernkvist M, Ebarasi L, Jakobsson L, Majumdar A, Yi C . Angiomotin regulates endothelial cell migration during embryonic angiogenesis. Genes Dev. 2007; 21(16):2055-68. PMC: 1948860. DOI: 10.1101/gad.432007. View

Moleirinho S, Guerrant W, Kissil J . The Angiomotins--from discovery to function. FEBS Lett. 2014; 588(16):2693-703. PMC: 4112001. DOI: 10.1016/j.febslet.2014.02.006. View

Schutte U, Bisht S, Heukamp L, Kebschull M, Florin A, Haarmann J . Hippo signaling mediates proliferation, invasiveness, and metastatic potential of clear cell renal cell carcinoma. Transl Oncol. 2014; 7(2):309-21. PMC: 4101344. DOI: 10.1016/j.tranon.2014.02.005. View

Kikuno R, Nagase T, Ishikawa K, Hirosawa M, Miyajima N, Tanaka A . Prediction of the coding sequences of unidentified human genes. XIV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res. 1999; 6(3):197-205. DOI: 10.1093/dnares/6.3.197. View

Yi C, Shen Z, Stemmer-Rachamimov A, Dawany N, Troutman S, Showe L . The p130 isoform of angiomotin is required for Yap-mediated hepatic epithelial cell proliferation and tumorigenesis. Sci Signal. 2013; 6(291):ra77. PMC: 4175526. DOI: 10.1126/scisignal.2004060. View

Ernkvist M, Persson N, Audebert S, Lecine P, Sinha I, Liu M . The Amot/Patj/Syx signaling complex spatially controls RhoA GTPase activity in migrating endothelial cells. Blood. 2008; 113(1):244-53. PMC: 2614636. DOI: 10.1182/blood-2008-04-153874. View

Arigoni M, Barutello G, Lanzardo S, Longo D, Aime S, Curcio C . A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors. Angiogenesis. 2012; 15(2):305-16. PMC: 3338916. DOI: 10.1007/s10456-012-9263-3. View

Zhao B, Li L, Lu Q, Wang L, Liu C, Lei Q . Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev. 2011; 25(1):51-63. PMC: 3012936. DOI: 10.1101/gad.2000111. View

Wang Y, Dong Q, Zhang Q, Li Z, Wang E, Qiu X . Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer. Cancer Sci. 2010; 101(5):1279-85. PMC: 11158334. DOI: 10.1111/j.1349-7006.2010.01511.x. View

10.

Hsu Y, Hung J, Chou S, Huang M, Tsai M, Lin Y . Angiomotin decreases lung cancer progression by sequestering oncogenic YAP/TAZ and decreasing Cyr61 expression. Oncogene. 2014; 34(31):4056-68. DOI: 10.1038/onc.2014.333. View

11.

Chen W, Zheng R, Zeng H, Zhang S, He J . Annual report on status of cancer in China, 2011. Chin J Cancer Res. 2015; 27(1):2-12. PMC: 4329176. DOI: 10.3978/j.issn.1000-9604.2015.01.06. View

12.

Garnaas M, Moodie K, Liu M, Samant G, Li K, Marx R . Syx, a RhoA guanine exchange factor, is essential for angiogenesis in Vivo. Circ Res. 2008; 103(7):710-6. PMC: 2758496. DOI: 10.1161/CIRCRESAHA.108.181388. View

13.

Zhi X, Zhao D, Zhou Z, Liu R, Chen C . YAP promotes breast cell proliferation and survival partially through stabilizing the KLF5 transcription factor. Am J Pathol. 2012; 180(6):2452-61. DOI: 10.1016/j.ajpath.2012.02.025. View

14.

Zhao B, Ye X, Yu J, Li L, Li W, Li S . TEAD mediates YAP-dependent gene induction and growth control. Genes Dev. 2008; 22(14):1962-71. PMC: 2492741. DOI: 10.1101/gad.1664408. View

15.

Troyanovsky B, Levchenko T, Mansson G, Matvijenko O, Holmgren L . Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation. J Cell Biol. 2001; 152(6):1247-54. PMC: 2199208. DOI: 10.1083/jcb.152.6.1247. View

16.

Holmgren L, Ambrosino E, Birot O, Tullus C, Veitonmaki N, Levchenko T . A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth. Proc Natl Acad Sci U S A. 2006; 103(24):9208-13. PMC: 1482591. DOI: 10.1073/pnas.0603110103. View

17.

Pei T, Li Y, Wang J, Wang H, Liang Y, Shi H . YAP is a critical oncogene in human cholangiocarcinoma. Oncotarget. 2015; 6(19):17206-20. PMC: 4627302. DOI: 10.18632/oncotarget.4043. View

18.

Lv M, Lv M, Chen L, Qin T, Zhang X, Liu P . Angiomotin promotes breast cancer cell proliferation and invasion. Oncol Rep. 2015; 33(4):1938-46. DOI: 10.3892/or.2015.3780. View

19.

Flanigan R, Campbell S, Clark J, Picken M . Metastatic renal cell carcinoma. Curr Treat Options Oncol. 2003; 4(5):385-90. DOI: 10.1007/s11864-003-0039-2. View

20.

Huang H, Lu F, Jia S, Meng S, Cao Y, Wang Y . Amotl2 is essential for cell movements in zebrafish embryo and regulates c-Src translocation. Development. 2007; 134(5):979-88. DOI: 10.1242/dev.02782. View